# Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema

> **NCT06179030** · — · COMPLETED · sponsor: **Saglik Bilimleri Universitesi** · enrollment: 80 (actual)

## Conditions studied

- Diabetic Macular Edema
- Inflammation

## Interventions

- **DIAGNOSTIC_TEST:** serum samples
- **DRUG:** dexamethasone implant versus ranibizumab

## Key facts

- **NCT ID:** NCT06179030
- **Lead sponsor:** Saglik Bilimleri Universitesi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2023-10-17
- **Final completion:** 2023-10-17
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06179030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06179030, "Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06179030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*